Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention

Topuz, Mustafa; Oz, Fahrettin; Akkus, Oguz; Sen, Omer; Topuz, Ayse; Bulut, Atilla; Ozbicer, Suleyman; Okar, Sefa; Koc, Mevlut; Gur, Mustafa

doi:10.1177/0267659116676335

Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention

Atıf İçin Kopyala

Topuz M., Oz F., Akkus O., Sen O., Topuz A. N., Bulut A., ...Daha Fazla

PERFUSION-UK, cilt.32, sa.3, ss.206-213, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 3
Basım Tarihi: 2017
Doi Numarası: 10.1177/0267659116676335
Dergi Adı: PERFUSION-UK
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.206-213
Çukurova Üniversitesi Adresli: Evet

Özet

Objective: We aimed to investigate the compliance of plasma apelin-12 levels to show angiographic properties and hospital MACE in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).